The Effect of Food on the Pharmacokinetics of Zileuton
- 11 Downloads
The present study was undertaken to assess the effect of food on the pharmacokinetic parameters of zileuton. In a nonblinded crossover study, 18 healthy male volunteers who had fasted overnight were randomised to receive a single oral dose of zileuton 600mg in the presence or absence of food consisting of a standardised breakfast on the following morning. The mean zileuton peak plasma concentration (Cmax) increased significantly by 27% after food intake, while the mean area under the plasma concentration versus time curve increased by only 1.4%, a difference that was not statistically significant. The mean time to Cmax was unaffected by the presence of food, as were the other pharmacokinetic parameters assessed.
Overall, the results suggest that food has a relatively small effect on the rate of zileuton absorption compared with the fasting state, while the bioavailability of the drug appears to be unaffected. Thus, it is concluded that it is appropriate to administer zileuton with or without food.
KeywordsSingle Oral Dose Hepatic Blood Flow Zileuton High Performance Liquid Chroma Statistical Analysis System Institute
Unable to display preview. Download preview PDF.
- 8.Wong SL, Awni WM, Cavanaugh J, et al. The pharmacokinetics of single oral doses of zileuton 200 to 800mg, its enantiomers, and its metabolites, in normal healthy volunteers. Clin Pharmacokinet 29; Suppl. 2: 9–21Google Scholar
- 9.Granneman GR, Braeckman RA, Erdman KA. Determination of a new 5-lipoxygenase inhibitor, zileuton, and its inactive N-dehydroxylated metabolite in plasma by high performance liquid chromatography. Clin Pharmacokinet 29; Suppl. 2: 1–8Google Scholar
- 10.SAS Institute. The GLM Procedure. In: SAS/STAT user’s guide, Version 6. 4th ed., volume 2. Cary NC: SAS Institute, 1989: 891–996Google Scholar
- 13.Welling PG. Effects of gastrointestinal disease on drug absorption In: Benet LZ, Massod N, Gambertoglio JG, editors. Pharmacokinetic basis for drug treatment. New York: Raven Press, 1984: 29–47Google Scholar
- 14.Rowland M, Tozer TN. Integration with kinetics. In: Rowland M, Tozer TN. Clinical pharmacokinetics: concepts and applications. Philadelphia: Lea and Febiger, 1989: 177–93Google Scholar